Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLoans and Notes ReceivablesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Leases (2016 - 2025)

Lifecore Biomedical, Inc. \De\ has reported Leases over the past 11 years, most recently at $2.2 million for Q1 2025.

  • Quarterly results put Leases at $2.2 million for Q1 2025, down 11.04% from a year ago — trailing twelve months through Feb 2025 was $2.2 million (down 11.04% YoY), and the annual figure for FY2024 was $2.4 million, down 42.97%.
  • Leases for Q1 2025 was $2.2 million at Lifecore Biomedical, Inc. \De\, down from $2.3 million in the prior quarter.
  • Over the last five years, Leases for LFCR hit a ceiling of $15.4 million in Q1 2021 and a floor of $2.2 million in Q1 2025.
  • Median Leases over the past 5 years was $5.1 million (2023), compared with a mean of $5.6 million.
  • Biggest five-year swings in Leases: tumbled 62.97% in 2022 and later fell 10.57% in 2023.
  • Lifecore Biomedical, Inc. \De\'s Leases stood at $7.5 million in 2021, then decreased by 29.87% to $5.3 million in 2022, then decreased by 23.14% to $4.0 million in 2023, then crashed by 42.91% to $2.3 million in 2024, then dropped by 3.08% to $2.2 million in 2025.
  • The last three reported values for Leases were $2.2 million (Q1 2025), $2.3 million (Q4 2024), and $2.4 million (Q3 2024) per Business Quant data.